APL-2 clinical trials

A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects with Geographic Atrophy Secondary to Age-Related Macular Degeneration

This study looks at the long-term effects of a treatment called pegcetacoplan, also known as APL-2, for people with a common eye condition called Geographic Atrophy. Researchers want to see if it's safe and helps slow down vision loss over time.